Christy L. Shaffer - General Partner @ Hatteras Venture Partners

Start Free Trial

Pricing

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title General Partner
Primary Organization
Hatteras Venture Partners

Location Raleigh, North Carolina, United States
Regions Research Triangle, East Coast, Southern US
Gender Female

Investor Type
obfuscated
obfuscation
Investor Stage
obfuscated
obfuscation

LinkedIn View on LinkedIn

Christy L. Shaffer is a General Partner at Hatteras Venture Partners and was a President and CEO at Inspire Pharmaceuticals. She attended The University of Tennessee Health Science Center.

Personal Investments

Number of Investments

Christy L. Shaffer

has made

investments. Their latest investment was

Series A - EvoApp

obfuscation

, when

EvoApp

raised

obfuscation

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	EvoApp	—	Series A - EvoApp	obfuscated obfuscation
obfuscated obfuscation	EvoApp	—	Angel Round - EvoApp	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Incyclix Bio	Hatteras Venture Partners	Yes	Series B - Incyclix Bio	obfuscated obfuscation
obfuscated obfuscation	Aer Therapeutics	Hatteras Venture Partners	—	Series A - Aer Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Trefoil Therapeutics	Hatteras Venture Partners	Yes	Series A - Trefoil Therapeutics	obfuscated obfuscation
obfuscated obfuscation	GrayBug	Hatteras Venture Partners	—	Series C - GrayBug	obfuscated obfuscation
obfuscated obfuscation	G1 Therapeutics	Hatteras Venture Partners	No	Series C - G1 Therapeutics	obfuscated obfuscation
obfuscated obfuscation	GrayBug	Hatteras Venture Partners	No	Series B - GrayBug	obfuscated obfuscation
obfuscated obfuscation	Spyryx Biosciences	Hatteras Venture Partners	Yes	Series A - Spyryx Biosciences	obfuscated obfuscation
obfuscated obfuscation	GrayBug	Hatteras Venture Partners	Yes	Series A - GrayBug	obfuscated obfuscation
obfuscated obfuscation	G1 Therapeutics	Hatteras Venture Partners	—	Series B - G1 Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Clearside Biomedical	Hatteras Venture Partners	No	Series B - Clearside Biomedical	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Christy L. Shaffer

has

current jobs including

Chair Of The Board Of Directors

Artizan Biosciences

Member Board Of Directors

The Chordoma Foundation

, and

General Partner

Hatteras Venture Partners

. Additionally,

Christy L. Shaffer

has had

past jobs including

President ,CEO , Board Member & Consultant

Inspire Pharmaceuticals

Artizan Biosciences Chair Of The Board Of DirectorsSep 2016
The Chordoma Foundation Member Board Of DirectorsJan 2016
Hatteras Venture Partners General Partner2016
Burroughs Wellcome Member of the Regulatory Initiative advisory boardJan 2016
Center for Entrepreneurial Development Steering Committee Member (LIFE SCIENCE CONFERENCE, 2015 and 2016)Oct 2014
Hatteras Venture Partners General Partner
Burroughs Wellcome Associate Director of Pulmonary and Critical Care Medicine
KinoDyn Board Chair

Organization Name	Title At Company	Start Date	End Date
Inspire Pharmaceuticals	President ,CEO , Board Member & Consultant	Jun 1995	Mar 2010
Inspire Pharmaceuticals	President and CEO	1995	Mar 1, 2010
Hatteras Venture Partners	Managing Director of Hatteras Discovery and General Partner (as of August, 2015)	2011	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Christy L. Shaffer

holds

board and advisor roles including

Board of Directors

Aer Therapeutics

Board of Directors

Trefoil Therapeutics

, and

Member of the Board of Governors, Chair of URCC Committee, Compensation and Finance Committees

RTI International

Aer Therapeutics Board of DirectorsApr 13, 2023
Trefoil Therapeutics Board of DirectorsDec 1, 2021
RTI International Member of the Board of Governors, Chair of URCC Committee, Compensation and Finance CommitteesMay 2018
Center for Entrepreneurial Development Board Member2016
GrayBug Chair of the Board, member of the Audit and Corporate Governance/Nominating CommitteesMar 2015
Spyryx Biosciences Board of Directors2015
Clearside Biomedical Board MemberJan 2012
Morehead Planetarium and Science Center Chair of Advisory Board; Member of Steering Committee for Capital CampaignOct 2008
Clearside Biomedical Board of Directors
G1 Therapeutics Executive Chair, Board

Organization Name	Title At Company	Start Date	End Date
EvoApp	Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Research Triangle Venture Capital Investors	83,439
Early Stage Venture Investors with Investments in Research Triangle	22,047
East Coast Convertible Note Investors	47,690
Venture Stage Investors with Investments in East Coast	5,039
Research Triangle Investors	56,101
Research Triangle Early Stage Venture Investors	85,549
Southern US Medical Companies (Top 10K)	3,284
Research Triangle Companies With Less Than $1B in Revenue	14,564
Southern US Venture Stage Investors	31,834
East Coast Financial Services Companies (Top 10K)	2,737